RSV TERAPEVTIKS, OOO, Moscow

Economic indicators

Net loss (RA) of RSV TERAPEVTIKS, OOO made up 22.60 million RUB over 2023 compared to net profit of 133.57 million RUB over 2022, the company informed.

Revenue decreased in the accounting period ? times to 0.00 thousand RUB from 375.63 million RUB in 2022; cost of goods sold decreased 11.34 times to 22.53 million RUB from 255.53 million RUB; sales loss made up 22.83 million RUB compared to sales profit of 119.71 million RUB.

Net profit (RAS) of RSV TERAPEVTIKS, OOO grew over 2022 9.78 times to 133.57 million RUB from 13.66 million RUB over 2021, the company informed.

Revenue increased in the accounting period 24.44 times to 375.63 million RUB from 15.37 million RUB over 2021; cost of goods sold grew 128.02 times to 255.53 million RUB from 2.00 million RUB; sales profit went up 9.26 times to 119.71 million RUB from 12.93 million RUB.

Net profit (RAS) of RSV TERAPEVTIKS, OOO made up 13.66 million RUB over 2021 compared to net loss of 2.65 million RUB over 2020, the company informed.

Cost of goods sold grew 22.18 times to 2.00 million RUB from 90.00 thousand RUB; sales profit made up 12.93 million RUB compared to sales loss of 518.00 thousand RUB.

Net loss (RAS) of RSV TERAPEVTIKS, OOO increased by 47.06% to 2.65 million RUB from 1.80 million RUB over 2019, the company informed.

Sales loss grew by 10.45% to 518.00 thousand RUB from 469.00 thousand RUB.

Companies in the region

• UPRAVSTROY
• STG
• STARVEY
• GRUZSERVIS
• BLOKCHEYN SERVIS